{
  "trial_id": "NCT00378222",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Previously untreated",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Younger than 61 years",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Symptomatic myeloma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Measurable disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Fit to receive high-dose chemotherapy",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "M-GUS",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Solitary plasmacytoma",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Plasma cell leukemia",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "AL Amyloidosis",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has multiple myeloma with systemic amyloidosis, which likely triggers exclusion criteria.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT00378222",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}